|
|
|
|
|
|
Focus Groups
Focus Groups |
Back |
| New
Scientists |
| [Group
Library] (members only) |
| |
|
Biography |
| |
| Helen L
Barker |
In 2006, Helen transitioned to the position of Pharmaceutical Sciences Team
Leader at Pfizer, leading the strategic and technical development of a
portfolio of inhaled and oral programs.
During her 10 years at Pfizer, Helen has led multidisciplinary and global
teams, designed several solid drug products, led the early formulations team
and developed several research projects. The latter included investigations
into reactions in the solid state, particle characterization, predictive
tests and intelligent software.
Helen graduated from the University of Sunderland, UK with a BSc. (Hons) in
Chemical and Pharmaceutical Science and worked for a year with Bristol-Myers
Squibb, primarily developing analytical methods for API and drug product.
Key interests include continuous improvement and educating key opinion
leaders, scientists and non-scientists in drug development. Favourite social
activities include visiting friends and family, music concerts and woodland
jaunts with Doobs the dog.
|
| Dr Hannah
Batchelor |
Dr Hannah Batchelor is a pharmaceutical scientist working for AstraZeneca
within pharmaceutical and analytical research and development. Previous to
this she was a lecturer at Aston University teaching pharmaceutics. Her
research interests encompass drug delivery systems and targeting the upper
gastro-intestinal tract, transdermal drug delivery and biopharmaceutics.
|
| Rachel
Bridson |
I graduated from Aston University with a degree in Pharmacy in 1998. I went
on to complete my pre-registration year with Boots the Chemists and thought
at that time that I would spend my career in community pharmacy. However, in
2000, I started a PhD with a view to moving to industry or academia. The
research for my PhD was carried out at Aston, the School of Pharmacy, GSK
and Birmingham University and spanned pharmaceutics and chemical
engineering. Towards the end of my studies I applied for a position as a
Teaching Fellow within the department of Chemical Engineering at Birmingham,
a role that involved designing and delivering modules in pharmaceutical
technology. I also co-supervised a number of PhD and Masters research
students. In 2005, I took on another role in Chemical Engineering that is
part sponsored by the UK’s Research Councils called an Academic Fellowship.
This is like a lectureship but allows greater emphasis on research. I now
have a number of PhD, Eng D and Masters students and carry out research in a
range of areas relating to pharmaceutical technology. I am also the
programme manager for the Department’s MSc in Advanced Chemical Engineering
and lecture to postgraduate and undergraduate students.
|
| Mike Cram
|
Mike
graduated in 1997 with a BSc. (Hons) in Chemical and Pharmaceutical Science
from the University of Sunderland. For the past 11 years, Mike has worked at
Pfizer within Research Formulation. During this time, he has been
responsible for implementing a number of automated screens focussed on
measurement of physicochemical properties and has led an number of global
teams interested in solubility measurement, prediction and data capture.
|
| Geoff
Davison |
Geoff joined the Bionow team at the Northwest Regional Development Agency (NWDA)
in July 2007 as Sector Development Manager for the Biomedical cluster of
companies. His role is to promote and grow the biomedical sector within the
Northwest working with both companies and HEI’s. Prior to this Geoff was
founder of Biorite Ltd., a spin-out company from the University of
Manchester, which merged to form Advanced Biomedical Ltd. in 2003 where he
was Technical Director.
Geoff has a PhD from the School of Pharmacy and Pharmaceutical Sciences,
Manchester University and a BSc (Hons.) degree in Biochemistry. He began his
career as a Postdoctoral Research Associate at the University for 4 years
prior to forming and running Biorite and Advanced Biomedical in order to
commercialise intellectual property developed during his research.
|
| Kieran
Lennon |
Kieran studied Pharmacy at Queen’s University Belfast and completed his pre-reg
training with Boots the Chemists. After two and a half years in community
pharmacy, Kieran spent 14 months in the Pharmaceutical Industry at Abbott
Laboratories in Operations. During this time he decided to undertake a PhD
at DeMontfort University, investigating factors influencing adhesion
behaviours of tablet film coats. Kieran is now working for AstraZeneca where
his key interests are focussed upon immediate release dosage formulations
and drug delivery options for poorly soluble compounds.
|
| Matthew
Reason |
Matt gradated from Bath University with a degree in Pharmacy in 1997 and
completed a PhD in Pharmaceutics at De Montfort University in 2003. In 2002
he joined GlaxoSmithKline in Pharmaceutical Development. Matt currently
works on a number of inhaled projects where he is responsible for the
development of the physical product.
|
| Claire
Thompson |
From a degree in Biochemistry at University of St. Andrews, Claire moved
into the pharmaceutical arena via a PhD at School of Pharmacy, University of
Nottingham. Here, she studied the fundamental mechanisms of drug crystal
growth using Atomic Force Microscopy under Professor Clive Roberts.
Claire then progressed into industry through a post-doctoral position at
Pfizer Global R&D, Sandwich, which was facilitated by the University of
Greenwich. It was here that she developed her expertise in assessing the
physical attributes of drug substance intended for inhaled formulations.
In March 2005, she took up her current position at GlaxoSmithKline. In her
role, Claire utilises a plethora of analytical techniques to assess the
physical properties of pharmaceutical material throughout the product
lifecycle.
|
| |
|
|
